EDMOND DE ROTHSCHILD HOLDING S.A. - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 2 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD HOLDING S.A. ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$69,000
+91.7%
300,000
+200.0%
0.00%0.0%
Q4 2021$36,000
-40.0%
100,0000.0%0.00%0.0%
Q3 2021$60,000
-45.9%
100,0000.0%0.00%
-66.7%
Q2 2021$111,000
-13.3%
100,0000.0%0.00%
-25.0%
Q1 2021$128,000100,0000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2022
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 1,781,617$637,0000.08%
Anson Funds Management LP 864,322$309,0000.03%
Virtu Financial LLC 307,275$110,0000.01%
D. E. Shaw & Co., Inc. 18,680,699$6,682,0000.01%
Renaissance Technologies 10,699,831$3,827,0000.01%
Point72 Hong Kong Ltd 348,383$125,0000.00%
MONECO Advisors, LLC 35,000$7,0000.00%
Purus Wealth Management, LLC 15,000$5,0000.00%
PRUDENTIAL FINANCIAL INC 6,929,345$2,479,0000.00%
ALPS ADVISORS INC 548,866$196,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders